CDKN2D anticorps (AA 1-166)
-
- Antigène Voir toutes CDKN2D Anticorps
- CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Épitope
- AA 1-166
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CDKN2D est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA
- Réactivité croisée
- Humain
- Purification
- Antigen Affinity Purified
- Immunogène
- Recombinant Human Cyclin-dependent kinase 4 inhibitor D protein (1-166AA)
- Isotype
- IgG
- Top Product
- Discover our top product CDKN2D Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
- Autre désignation
- CDKN2D (CDKN2D Produits)
- Synonymes
- anticorps ink4d, anticorps p19, anticorps p19-ink4d, anticorps CDKN2D, anticorps ank2, anticorps INK4D, anticorps p19-INK4D, anticorps INK4d, anticorps p19INK4d, anticorps cyclin-dependent kinase inhibitor 2D S homeolog, anticorps cyclin dependent kinase inhibitor 2D, anticorps cyclin-dependent kinase inhibitor 2D, anticorps Cyclin-dependent kinase 4 inhibitor D, anticorps cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4), anticorps similar to cyclin-dependent kinase inhibitor 2D, anticorps cdkn2d.S, anticorps CDKN2D, anticorps cdkn2d, anticorps cdn2d, anticorps Cdkn2d
- Sujet
-
Background: Interacts strongly with CDK4 and CDK6 and inhibits them.
Aliases: CDKN2DCyclin-dependent kinase 4 inhibitor D antibody, p19-INK4d antibody
- UniProt
- P55273
- Pathways
- Cycle Cellulaire, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling
-